Focus
Novo Nordisk
Ozempic’s Sister Drug Reduces Cardiovascular Risk by 14 Percent in Large-Scale Trial
Learn about the study’s possible impact on treatment strategies.
Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
The company said it conducted tests on compounded drugs that claim to contain semaglutide and found ‘concerning levels of unknown impurities.’
FDA Found Bacterial Contamination at Novo Nordisk Diabetes Pill Manufacturing Facility
The contamination does not affect its popular weight loss drugs Wegovy and Ozempic, according to the company.
